Related Experiment Video
Updated: Jul 24, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Apical Hypertrophic Cardiomyopathy: Diagnosis, Natural History, and Management
Pavlos Rouskas1, Sotiris Katranas1, Thomas Zegkos1
1From the First Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.
Insights
Apical hypertrophic cardiomyopathy (ApHCM) is a rare heart condition. Diagnosis uses echocardiography and cardiac MRI, with prognosis evolving from benign to similar to general hypertrophic cardiomyopathy (HCM).
Area of Science:
- Cardiology
- Cardiovascular Imaging
Background:
- Apical hypertrophic cardiomyopathy (ApHCM) is a rare variant of hypertrophic cardiomyopathy (HCM).
- Its prevalence varies geographically.
- Distinct phenotypic characteristics differentiate ApHCM from other HCM forms.
Purpose of the Study:
- To review diagnostic methods for ApHCM.
- To compare ApHCM with other HCM types regarding natural history and prognosis.
- To summarize management strategies for ApHCM.
Main Methods:
- Echocardiography is the primary diagnostic tool.
- Cardiac magnetic resonance (CMR) serves as the gold standard for challenging cases.
- Review of existing literature on ApHCM diagnosis, prognosis, and management.
Main Results:
- Echocardiography is the leading imaging modality for ApHCM diagnosis.
- CMR is crucial for poor acoustic windows, equivocal findings, and suspected apical aneurysms.
- Recent studies suggest ApHCM may have a similar adverse event incidence as general HCM, challenging its previously reported benign prognosis.
Conclusions:
- ApHCM diagnosis relies on echocardiography and CMR.
- The natural history and prognosis of ApHCM require further investigation.
- Management strategies should be tailored, considering evolving prognostic data.
Abstract:
Apical hypertrophic cardiomyopathy (ApHCM) represents a rare variant of hypertrophic cardiomyopathy (HCM) with distinct phenotypic characteristics. The prevalence of this variant varies according to each study's geographic region. The leading imaging modality for the diagnosis of ApHCM is echocardiography. Cardiac magnetic resonance, however, is the gold standard for ApHCM diagnosis in case of poor acoustic windows or equivocal echocardiographic findings but also in cases of suspected apical aneurysms. The prognosis of ApHCM was reported to be relatively benign, although more recent studies seem to contradict this, demonstrating similar incidence of adverse events compared with the general HCM population. The aim of this review is to summarize the available evidence for the diagnosis of ApHCM, highlight distinctions in comparison to more frequent forms of HCM with regards to its natural history, prognosis, and management strategies.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VI: Nursing Management

